Search Within

Antonio Marcilio Padula Omuro

Formats
  1. Meeting Abstract (105)
  2. Journal Article (96)
  3. Book Section (2)
  4. Research Letter (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (92)
  2. GSK Faculty (57)
  3. Radiology, Department of (46)
  4. Human Oncology and Pathogenesis Program (43)
  5. Neuroradiology Service (41)
  6. Epidemiology and Biostatistics (37)

More Groups

People
  1. Lisa De Angelis (81)
  2. Lauren Abrey (41)
  3. Thomas Kaley (38)
  4. Ingo Mellinghoff (36)
  5. Elena Pentsova (33)
  6. Craig Nolan (26)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (2)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (5)

More Years

Publications
  1. Neuro-Oncology (63)
  2. Journal of Clinical Oncology (48)
  3. Journal of Neuro-Oncology (11)
  4. Neurology (8)
  5. Blood (6)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. Oxford University Press (68)
  2. American Society of Clinical Oncology (49)
  3. Springer (17)
  4. Lippincott Williams & Wilkins (11)
  5. Elsevier Inc. (10)
  6. Wiley Blackwell (7)

More Publishers

Results (204)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cognitive functions in primary CNS lymphoma after single or combined modality regimens
    Journal Article

    Correa, D. D.; Shi, W.; Abrey, L. E.; De Angelis, L. M.; Omuro, A. M.; Deutsch, M. B.; Thaler, H. T.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Prophylactic intrathecal chemotherapy in primary CNS lymphoma
    Journal Article

    Sierra Del Rio, M.; Ricard, D.; Houillier, C.; Navarro, S.; Gonzalez-Aguilar, A.; Idbaih, A.; Kaloshi, G.; Elhallani, S.; Omuro, A.; Choquet, S.; more...
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Targeted therapy for malignant gliomas
    Journal Article

    Dankwah-Quansah, M.; Omuro, A. M.
    Tumors of the Central Nervous System (2011)

    Fulltext@MSK | Save
  • Methotrexate (MTX) rechallenge for recurrent primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Pentsova, E.; DeAngelis, L. M.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01
    Meeting Abstract

    Nayak, L.; Abrey, L. E.; Drappatz, J.; Gilbert, M. R.; Reardon, D. A.; Lamborn, K.; Wen, P. Y.; Prados, M.; DeAngelis, L. M.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM)
    Meeting Abstract

    Graber, J. J.; Young, R. J.; Gupta, A.; Shah, A. D.; Chan, T. A.; Zhang, Z.; Shi, W.; Beal, K.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
    Meeting Abstract

    Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I study of aflibercept (VEGF Trap) and temozolomide in newly diagnosed, high-grade glioma
    Meeting Abstract

    De Groot, J. F.; Cloughesy, T.; Lieberman, F. S.; Chang, S. M.; Omuro, A. M. P.; Drappatz, J.; Batchelor, T.; DeAngelis, L. M.; Gilbert, M. R.; Yung, W. K. A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy
    Meeting Abstract

    Correa, D. D.; Baser, R.; Beal, K.; Karimi, S.; DeAngelis, L.; Panageas, K.; Barradas, R.; Statucka, M.; Abrey, L.; Gutin, P.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save